1 Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products, Saint-Denis, France; Department of Pharmacy, Centre hospitalo-universitaire Hôpital Henri Mondor Assistance Publique des Hôpitaux de Paris, Créteil, France.
2 Department of Oncohematology, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
3 Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products, Saint-Denis, France; Department of Oncohematology, Avec Groupe Hospitalier Mutualiste, Grenoble, France.
4 Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products, Saint-Denis, France.
5 Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
6 Oncology Hematology and Cell Therapy Department, French National Agency for Safety of Medicines and Health Products, Saint-Denis, France; Department of Oncohematology, Avec Groupe Hospitalier Mutualiste, Grenoble, France. Electronic address: nicolas.albin@ansm.sante.fr.